These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2696307)

  • 41. The chamber vasoconstrictor assay. I. Comparison with occluded and unoccluded tests using four corticosteroids.
    Somerma S
    Clin Exp Dermatol; 1980 Jun; 5(2):191-6. PubMed ID: 7438514
    [No Abstract]   [Full Text] [Related]  

  • 42. Quantification of skin-colour changes induced by topical corticosteroid preparations using the Minolta Chroma Meter.
    Queille-Roussel C; Poncet M; Schaefer H
    Br J Dermatol; 1991 Mar; 124(3):264-70. PubMed ID: 2018732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topical calcitriol restores the impairment of epidermal permeability and antimicrobial barriers induced by corticosteroids.
    Hong SP; Oh Y; Jung M; Lee S; Jeon H; Cho MY; Lee SH; Choi EH
    Br J Dermatol; 2010 Jun; 162(6):1251-60. PubMed ID: 20302580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Steroid-induced vasoconstriction: glucocorticoid antagonist studies.
    Marks R; Barlow JW; Funder JW
    J Clin Endocrinol Metab; 1982 May; 54(5):1075-7. PubMed ID: 7061698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the vasoconstrictive effects of topical steroids by laser-Doppler-perfusion-imaging.
    Sommer A; Veraart J; Neumann M; Kessels A
    Acta Derm Venereol; 1998 Jan; 78(1):15-8. PubMed ID: 9498019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [External administration of glucocorticosteroids. Part 1: Administration guidelines--classification].
    Niedner R
    Fortschr Med; 1992 Jun; 110(17):327-9. PubMed ID: 1644391
    [No Abstract]   [Full Text] [Related]  

  • 47. Influence of glucocorticoids on the epidermal Langerhans cell.
    Mommaas AM
    Curr Probl Dermatol; 1993; 21():67-72. PubMed ID: 8299378
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of topical corticosteroids on the activity of superoxide dismutase in human skin in vitro.
    Gavan N; Maibach H
    Skin Pharmacol; 1997; 10(5-6):309-13. PubMed ID: 9449171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of topically applied glucocorticosteroids on patch test responses and recruitment of inflammatory cells in allergic contact dermatitis.
    Prens EP; Benne K; Geursen-Reitsma AM; van Dijk G; Benner R; van Joost T
    Agents Actions; 1989 Jan; 26(1-2):125-7. PubMed ID: 2711931
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potency assessment of topical corticoids in the vasoconstrictor assay and on tuberculin-induced inflammation.
    Schalla W; Schorning S
    Skin Pharmacol; 1991; 4(3):191-204. PubMed ID: 1768431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of drug metabolising enzymes in the skin by topical steroids.
    Finnen MJ; Herdman ML; Shuster S
    J Steroid Biochem; 1984 May; 20(5):1169-73. PubMed ID: 6610079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of topical corticosteroids on human sebum production assessed by two different methods.
    Lévêque JL; Pierard-Franchimont C; de Rigal J; Saint-Léger D; Piérard GE
    Arch Dermatol Res; 1991; 283(6):372-6. PubMed ID: 1796819
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Corticosteroid effect on epidermal cell size.
    Delforno C; Holt PJ; Marks R
    Br J Dermatol; 1978 Jun; 98(6):619-23. PubMed ID: 678451
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo characterization of structural changes after topical application of glucocorticoids in healthy human skin.
    Jung S; Lademann J; Darvin ME; Richter C; Pedersen CB; Richter H; Schanzer S; Kottner J; Blume-Peytavi U; Røpke MA
    J Biomed Opt; 2017 Jul; 22(7):76018. PubMed ID: 28753693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topical corticosteroid inhibits autoregulation of cutaneous blood flow.
    Petersen LJ; Kristensen JK
    Scand J Clin Lab Invest; 1989 Apr; 49(2):189-93. PubMed ID: 2520372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reflectance spectrophotometric quantification of skin colour changes induced by topical corticosteroid preparations.
    Feather JW; Ryatt KS; Dawson JB; Cotterill JA; Barker DJ; Ellis DJ
    Br J Dermatol; 1982 Apr; 106(4):437-43. PubMed ID: 7073967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Org 6216: a novel type of anti-inflammatory steroid [proceedings].
    Lewis AJ; Fox PK
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():82P. PubMed ID: 12362
    [No Abstract]   [Full Text] [Related]  

  • 58. Penetration of topical corticosteroids through human epidermis.
    Osamura H
    J Dermatol; 1982 Feb; 9(1):45-58. PubMed ID: 7047607
    [No Abstract]   [Full Text] [Related]  

  • 59. [Topically administered glucocorticosteroids. Part 2: Dose effect--preparations].
    Niedner R
    Fortschr Med; 1992 Jun; 110(18):345. PubMed ID: 1644395
    [No Abstract]   [Full Text] [Related]  

  • 60. Morphologic investigations on the rebound phenomenon after corticosteroid-induced atrophy in human skin.
    Zheng PS; Lavker RM; Lehmann P; Kligman AM
    J Invest Dermatol; 1984 Apr; 82(4):345-52. PubMed ID: 6368701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.